Thomas A Forbes

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Emergency Department

Nitric Oxide Synthase

Chronic Kidney Disease

Top Venues

Journal of paediatrics and child health

Science advances

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Freya Bleathman, Joshua Y Kausman, Laine M Hosking, Thomas A Forbes
Ravulizumab facilitates reduced burden of vascular access, a major benefit in paediatric atypical haemolytic uraemic syndrome. Journal of paediatrics and child health 60 (6) (2024)
Freya Bleathman, Joshua Y Kausman, Laine M Hosking, Thomas A Forbes
Ravulizumab facilitates reduced burden of vascular access, a major benefit in paediatric atypical haemolytic uraemic syndrome. Journal of paediatrics and child health (2024)
Freya Bleathman, Joshua Y Kausman, Laine M Hosking, Thomas A Forbes
Ravulizumab facilitates reduced burden of vascular access, a major benefit in paediatric atypical haemolytic uraemic syndrome. Journal of paediatrics and child health 60 (6) (2024)
Thomas A Forbes, Jane Wallace, Smitha Kumble, Martin B Delatycki, Zornitza Stark
Neonatal Bartter syndrome diagnosed by rapid genomics following low risk pre-conception carrier screening. Journal of paediatrics and child health 58 (5) (2022)
Amar J Majmundar, Florian Buerger, Thomas A Forbes, Verena Klämbt, Friedhelm Hildebrandt, Konstantin Deutsch, Thomas M Kitzler, Sara E Howden, Michelle Scurr, Ker Sin Tan, Mickaël Krzeminski, Eugen Widmeier, Daniela A Braun, Ethan Lai, Ihsan Ullah, Ali Amar, Amy Kolb, Kaitlyn Eddy, Chin Heng Chen, Daanya Salmanullah, Rufeng Dai, Makiko Nakayama, Isabel Ottlewski, Caroline M Kolvenbach, Ana C Onuchic-Whitford, Youying Mao, Nina Mann, Marwa M Nabhan, Seymour Rosen, Julie Deborah Forman-Kay, Neveen A Soliman, Andreas Heilos, Renate Kain, Christoph Aufricht, Shrikant M Mane, Richard P Lifton, Shirlee Shril, Melissa H Little, Friedhelm Hildebrandt
Recessive NOS1AP variants impair actin remodeling and cause glomerulopathy in humans and mice. Science advances 7 (1) (2021)
Thomas A Forbes, Bob D Brown, Chengjung Lai
Therapeutic RNA interference: A novel approach to the treatment of primary hyperoxaluria. British journal of clinical pharmacology (2021)